Down Round
Financing at a lower per-share price than the previous round.
Definition
A down round prices new shares below the prior round's price per share, typically triggering anti-dilution adjustments and signaling that the company has missed expectations. Down rounds can trigger anti-dilution adjustments, reduce employee option value and require consent of existing preferred holders. Companies sometimes pair them with recapitalizations or pay-to-play terms. Boards need careful process, often including a rights offering, to reduce fiduciary risk.What this means in practice
MedTech down rounds frequently follow failed pivotal trials, FDA non-clearances, or post-market safety signals. A well-structured 'pay-to-play' can keep insiders engaged and prevent worst-case dilution math.Examples
- A MedTech startup fails to secure FDA 510(k) clearance for its new diagnostic device after unexpected clinical trial results, leading to a down round for its next funding round.
- A company faces a significant product recall due to a manufacturing defect traced back to poor quality controls, resulting in a devaluation and a subsequent down round.
- A post-market surveillance report reveals a previously unknown safety issue with an implanted device, requiring extensive remediation efforts and causing investors to re-price the company in a down round.
- •Failing to understand that a down round often signals underlying issues in regulatory strategy, quality management, or product development lifecycle.
- •Assuming that financial remedies like "pay-to-play" provisions negate the need for addressing the root causes related to regulatory non-compliance or product quality.
- •Neglecting to perform a thorough post-market surveillance and corrective and preventive action (CAPA) process after a significant product issue, which could lead to a down round.
- •Underestimating the impact of regulatory non-compliance fines or market withdrawals, which can be precursors to a down round, on investor confidence.
- •Not recognizing that repeated down rounds can indicate systemic problems in a company's ability to meet regulatory milestones or product performance expectations.
Frequently asked questions
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsAdjustment that protects investors if the company raises a future round at a lower price.
A charter or agreement provision that penalizes existing preferred stockholders (often by converting their preferred to common) if they do not participate pro rata in a future down round.
More in Investment & Finance
· Same categoryAn independent fair-market-value appraisal of common stock used to set tax-compliant strike prices for employee stock options.
The governing body elected by stockholders that oversees management, approves major corporate actions, and typically includes investor-designated seats after venture financing.
Interim financing between priced rounds, usually convertible.
Rate at which a company spends cash, typically expressed monthly.
Where this term appears across MedTech Terms.
Sources
4 sourcesSources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
- 1Cooley GO: down roundsTier 4 VerifiedCooley GOcooleygo.com
- 2NVCA Model DocumentsTier 4 VerifiedNVCAnvca.org
- 3Silicon Valley Bank - Healthcare ReportsTier 4 VerifiedSVBsvb.com
- 4FASB ASU 2017-11: down-round price-adjustment features (accounting context)Tier 1 VerifiedFinancial Accounting Standards Board, 13 July 2017 news release on ASU 2017-11fasb.org
Inline markers like [1] jump to the matching reference above.